234 related articles for article (PubMed ID: 25788426)
41. Secondary preeclampsia in rats with nephrotic syndrome -- experimental model.
Pedrycz A; Wieczorski M; Czerny K
Reprod Toxicol; 2005; 19(4):493-500. PubMed ID: 15749263
[TBL] [Abstract][Full Text] [Related]
42. Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor.
Vaziri ND; Gollapudi P; Han S; Farahmand G; Yuan J; Rahimi A; Moradi H
Nephrol Dial Transplant; 2011 Oct; 26(10):3118-23. PubMed ID: 21459782
[TBL] [Abstract][Full Text] [Related]
43. Concentrating defect in experimental nephrotic syndrone: altered expression of aquaporins and thick ascending limb Na+ transporters.
Fernández-Llama P; Andrews P; Ecelbarger CA; Nielsen S; Knepper M
Kidney Int; 1998 Jul; 54(1):170-9. PubMed ID: 9648076
[TBL] [Abstract][Full Text] [Related]
44. Induction of proteinuric chronic glomerular disease in the rat (Rattus norvegicus) by intracardiac injection of doxorubicin hydrochloride.
Rangan GK; Wang Y; Harris DC
Contemp Top Lab Anim Sci; 2001 Sep; 40(5):44-9. PubMed ID: 11560405
[TBL] [Abstract][Full Text] [Related]
45. Rodent models to study sodium retention in experimental nephrotic syndrome.
Xiao M; Bohnert BN; Grahammer F; Artunc F
Acta Physiol (Oxf); 2022 Jul; 235(3):e13844. PubMed ID: 35569011
[TBL] [Abstract][Full Text] [Related]
46. Enhanced expression of the cytoskeletal-associated protein, paxillin, in experimental nephrotic syndrome.
Koukouritaki SB; Tamizuddin A; Lianos EA
J Investig Med; 1998 Aug; 46(6):284-9. PubMed ID: 9737090
[TBL] [Abstract][Full Text] [Related]
47. [Gene expression of heparanase in peripheral blood leukocytes from rats with nephrotic syndrome and its relationship to proteinuria].
Yan Y; Wang Z; Luo W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):489-91. PubMed ID: 15291107
[TBL] [Abstract][Full Text] [Related]
48. Nephrotic syndrome and acute renal failure during pegylated liposomal doxorubicin treatment.
Carron PL; Padilla M; Maurizi Balzan J
Hemodial Int; 2014 Oct; 18(4):846-7. PubMed ID: 25040096
[No Abstract] [Full Text] [Related]
49. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.
Doucet A; Favre G; Deschênes G
Pediatr Nephrol; 2007 Dec; 22(12):1983-90. PubMed ID: 17554565
[TBL] [Abstract][Full Text] [Related]
50. [The effect of chronic administration of ethanol on experimental adriamycin nephropathy].
Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
Cas Lek Cesk; 1994 May; 133(9):268-71. PubMed ID: 8194094
[TBL] [Abstract][Full Text] [Related]
51. Features of proteinuria in rat kidney in experimental nephrotic syndrome.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2000; 55():275-9. PubMed ID: 11482086
[No Abstract] [Full Text] [Related]
52. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
Pedraza-Chaverrí J; Cruz C; Chávez MT; López A; Ibarra-Rubio ME; Tapia E; Peña JC
Rev Invest Clin; 1990; 42(2):120-6. PubMed ID: 2267444
[TBL] [Abstract][Full Text] [Related]
53. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.
Bertani T; Poggi A; Pozzoni R; Delaini F; Sacchi G; Thoua Y; Mecca G; Remuzzi G; Donati MB
Lab Invest; 1982 Jan; 46(1):16-23. PubMed ID: 6172662
[TBL] [Abstract][Full Text] [Related]
54. [Changes of glomerular fixed anionic charge sites in adriamycin nephrosis in rats].
Wang Z; Wang ZG; Liu Z
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Dec; 20(4):405-8. PubMed ID: 2483554
[TBL] [Abstract][Full Text] [Related]
55. Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model.
Bulucu F; Oktenli C; Kenar L; Koc B; Ocal R; Karadurmus N; Inal V; Yamanel L; Sanisoglu YS; Aydin A
Int J Toxicol; 2007; 26(6):525-32. PubMed ID: 18066968
[TBL] [Abstract][Full Text] [Related]
56. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
[TBL] [Abstract][Full Text] [Related]
57. [Nephrotic syndrome: pathophysiology, classification and diagnostic criteria].
Togawa A; Yamamoto T; Hishida A
Nihon Rinsho; 2004 Oct; 62(10):1777-83. PubMed ID: 15500118
[TBL] [Abstract][Full Text] [Related]
58. Structure-activity relationship for two lipoxygenase inhibitors and their potential for inducing nephrotic syndrome.
Morley TJ; Evans GO; Goodwin DA; Read NG; Hodgson ST; Hawksworth GM
Toxicol Appl Pharmacol; 1997 Oct; 146(2):299-308. PubMed ID: 9344898
[TBL] [Abstract][Full Text] [Related]
59. The effect of aldosterone antagonist in experimental nephropathy induced by cyclosporine A.
Silva FM; Miorin LA; Sens YA
Ren Fail; 2008; 30(4):439-42. PubMed ID: 18569919
[TBL] [Abstract][Full Text] [Related]
60. Effect of heparin on the anionic sites of glomerular basement membrane in adriamycin nephrosis in rats.
Chen ZY; Jiang XY; Fei L
Chin Med J (Engl); 1992 Aug; 105(8):671-5. PubMed ID: 1458971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
